Manufacturer record

Aurio Pharma Laboratories Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Aurio Pharma Laboratories Pvt. Ltd (West Bengal) were declared Not of Standard Quality between February 2024 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Aurio Pharma Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2024 to Jul 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2024
3
Products affected
Assay
Most common failure
Jul 2025
Latest alert

Flagged batches per year

2024 · 22025 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Rabcprazole Tablets I.P. 20mg. 2378026Mfg 2023-10 · Exp 2025-09 The sample does not conform to claim with respect of 'Assay' test.Assay State Drugs Testing Laboratory, Kolkata, West BengalState lab Jul 2025
Rabcprazole Tablets I.P. 20mg. 2378021Mfg 2023-08 · Exp 2025-07 The sample does not conform to claim with respect to 'Identification' test. The sample declared as Spurious as per D&C Act 1940.Identification State Drugs Testing Laboratory, Kolkata, West BengalState lab Jul 2025
Rabcprazole Tablets I.P. 20mg. 2378028Mfg 2023-11 · Exp 2025-10 The sample does not conform to claim with respect to 'Identification' test. The sample declared as Spurious.Identification State Drugs Testing Laboratory, Kolkata, West BengalState lab Jul 2025
Ambroxol, Guaiphenesin, Terbutaline and Menthol (Bromodex - T) BDT-1257Mfg 2023-12 · Exp 2025-05 Assay of MentholAssay CDL KolkataCDSCO lab Apr 2024
Ciprofloxacin Hydrochloride Tablets IP 500 mg 2331044Mfg 2023-07 · Exp 2026-06 DissolutionDissolution CDL KolkataCDSCO lab Feb 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.